Enhancement of anti-inflammatory activity of glycyrrhizic acid by encapsulation in chitosan-katira gum nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 105, Issue , 2016, Pages 141-147

  Bernela, Manju ^a   Ahuja, Munish ^a   Thakur, Rajesh ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Anti inflammatory; Chitosan; Cochlospermum religiosum; Glycyrrhizic acid; Katira gum nanoparticles

Indexed keywords

AMMONIA; CARBOXYL GROUP; CHITOSAN KATIRA GUM NANOPARTICLE; CHITOSAN NANOPARTICLE; DICLOFENAC; GLYCYRRHIZIC ACID; NANOCARRIER; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CHITOSAN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARRAGEENAN-INDUCED PAW EDEMA; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFUSION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; RAT; RESPONSE SURFACE METHOD; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG FORMULATION; GINGIVA;

ANTI-INFLAMMATORY AGENTS; CHITOSAN; DRUG COMPOUNDING; GINGIVA; GLYCYRRHIZIC ACID; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES;

EID: 84974654771     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.06.003     Document Type: Article

References (43)

1. T.C. Kao, M.H. Shyu, and G.C. Yen Glycyrrhizic acid and 18 β-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3β signaling and glucocorticoid receptor activation J. Agric. Food Chem. 58 2010 8623 8629
2. D. Armanini, I. Karbowiak, and J.W. Funder Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors Clin. Endocrinol. 19 1983 609 612
3. E. Okimasu, Y. Moromizato, S. Watanabe, J. Sasaki, N. Shiraishi, Y.M. Morimoto, M. Miyahara, and K. Utsumi Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an anti inflammation drug Acta Med. Okayama 37 1983 385 391
4. K. Ohuchi, Y. Kamada, L. Levine, and S. Tsurufuji Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats Prostaglandins Med. 7 1981 457 463
5. L. Račková, V. Jančinová, M. Petríková, K. Drábiková, R. Nosáľ, M. Štefek, D. Kostálová, N. Prónayová, and M. Kovácová Mechanism of anti-inflammatory action of liquorice extract and glycyrrhizin Nat. Prod. Res. 21 2007 1234 1241
6. A. Kumagai, S. Yano, M. Otomo, and et al. Study on the corticoid-like action of glycyrrhizin and mechanism of its action Endocrinol. Jpn. 4 1957 17 27
7. X. Sui, W. Wei, L. Yang, Y. Zu, C. Zhao, L. Zhang, F. Yang, and Z. Zhang Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process Int. J. Pharm. 423 2012 471 479
8. Y. Oketani, I. Takehara, H. Mikuni, T. Shiraishi, K. Wakamatsu, H. Watanabe, and T. Tanaka Pharmacokinetics at oral administration of glycyrrhizic acid dosage form in normal humans: plasma concentration-time profiles of glycyrrhizic acid and glycyrrhetinic acid Clin. Rep. 19 1985 197 206
9. S. Ishida, Y. Sakiya, T. Ichikawa, and S. Awazu Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats Chem. Pharm. Bull. 37 1989 2509 2513
10. P.W. Stwart, A.M. Wallace, R. Valentino, and et al. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age Lancet 2 1987 281 284
11. Y. Kageyama, H. Suzuki, and T. Saruta Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney J. Endocrinol. 135 1992 147 152
12. Q.Y. Yuan, H.Y. Liu, K. Zhou, and B.J. Shi Pharmacokinetics of glycyrrhizin liposome and glycyrrhizin Chinese J. New Drugs 7 2005 903 905
13. A.H. Lin, Y.M. Liu, Y. Huang, J.B. Sun, Z.F. Wu, X.F. Zhang, and Q.N. Ping Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery Int. J. Pharm. 359 2008 247 253
14. Q.H. Cui, J.H. Cui, and J.J. Zhang Preparation of coated tablets of glycyrrhetic acid-HP-beta-cyclodextrin tablets for colon-specific release Chin. J. Chin. Mater. Med. 33 2008 2339 2343
15. K.A. Janes, P. Calvo, and M.J. Alonso Polysaccharide colloidal particles as delivery systems for macromolecules Adv. Drug Deliv. Rev. 47 2001 83 97
16. S. Nicol Life after death for empty shells New Sci. 129 1991 46 48
17. S. Miyazaki, K. Ishii, and T. Nadai Pharmaceutical application of biomedical polymers. Part IV. The use of chitin and chitosan as drug carriers Chem. Pharm. Bull. 29 1981 3067 3069
18. I. Genta, F. Pavanetto, B. Conti, P. Giunchedi, and U. Conte Spray-drying for the preparation of chitosan microspheres Proc. Int. Symp. Control. Release Bioact. Mater. 21 1994 616 617
19. Y. Sawayanagi, N. Nambu, and T. Nagai Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan Chem. Pharm. Bull. 31 1983 2507 2509
20. J.M. Gallo, and E.E. Hassan Receptor-mediated magnetic carriers: basis for targeting Pharm. Res. 5 1988 300 304
21. E.E. Hassan, R.C. Parish, and J.M. Gallo Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole Pharm. Res. 9 1992 390 397
22. A. Kilaru, B. Pal, and S. Antony Isolation of chitosan from Bridelia retusa for analgesic and anti-inflammatory activities Res. J. Pharm. Biol. Chem. Sci. 2 3 2011 349 357
23. P.C. Berscht, B. Nies, A. Liebendorfer, and J. Kreuter Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics Biomaterials 15 1994 593 600
24. K. Arai, T. Kinumaki, and T. Fujita Toxicity of chitosan Bull. Tokai Reg. Fish Lab. 43 1968 89 94
25. A. Ojha, D. Maiti, K. Chandra, S. Mondal, D. Roy, K. Ghosh, and S. Islam Structural assignment of a heteropolysaccharide isolated from the gum of Cochlospermum religiosum (Katira gum) Carbohydr. Res. 343 2008 1222 1231
26. V.K. Sharma, and B. Mazumdar Feasibility and characterization of gummy exudate of Cochlospermum religiosum as pharmaceutical excipient Ind. Crop. Prod. 50 2013 776 786
27. P. Girotra, and S.K. Singh Formulation optimization for colon targeted delivery of katira gum matrix tablets containing azathioprine Int. J. Pharm. Sci. Drug Res. 5 4 2013 133 140
28. B. Bharaniraja, K.J. Kumar, C.M. Prasad, and A.K. Sen Different approaches of katira gum formulations for colon targeting Int. J. Biol. Macromol. 49 2011 305 310
29. K. Srinivasa, B.V.S. Chandrasekhar, and J. Srinivasa Anti-inflammatory activity of theophylline on carrageenan-induced paw edema in male wistar rats Int. J. Basic Clin. Pharmacol. 2 3 2013 298 301
30. M. Yadav, and M. Ahuja Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery Carbohydr. Polym. 81 2010 871 877
31. A. Gèze, J.L. Putaux, L. Choisnard, P. Jéhan, and D. Wouessidjewe Long-term shelf stability of amphiphilic b-cyclodextrin nanosphere suspensions monitored by dynamic light scattering and cryo-transmission electron microscopy J. Microencapsul. 21 6 2004 607 613
32. Y. Zu, L. Meng, X. Zhao, Y. Ge, X. Yu, Y. Zhang, and Y. Deng Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery Int. J. Nanomed. 8 2013 1207 1222
33. Y. Wu, W. Yang, C. Wang, J. Hu, and S. Fu Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate Int. J. Pharm. 295 2005 235 245
34. F. Shamsa, K. Ohtsuki, E. Hasanzadeh, and Sh. Rezazadeh The anti-inflammatory and anti-viral effects of an ethnic medicine: glycyrrhizin J. Med. Plants 9 6 2010
35. Y. Shimoyama, H. Ohtaka, N. Nagata, and K. Ohtsuki Physiological correlation between glycyrrhizin, glycyrrhizin-binding lipoxygenase and casein kinase II FEBS Lett. 12 1996 238 242
36. Y. Abe, Y. Shimoyama, H. Munakata, J. Ito, N. Nagata, and K. Ohtsuki Characterization of an apoptosis-inducing factor in Habu snake venom as a glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro Biol. Pharm. Bull. 21 1998 924 927
37. K. Ohtsuki, Y. Abe, Y. Shimoyama, T. Furuya, H. Munakata, and C. Takasaki Separation of phospholipase A2 in Habu snake venom by glycyrrhizin-affinity column chromatography and identification of a GL-sensitive enzyme Biol. Pharm. Bull. 21 1998 574 578
38. Y. Shimoyama, R. Sakamoto, T. Akaboshi, M. Tanaka, and K. Ohtsuki Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro Biol. Pharm. Bull. 24 2001 1004 1008
39. I.M. Francischetti, R.Q. Monteiro, and J.A. Guimaraes Identification of glycyrrhizin as a thrombin inhibitor Biochem. Biophys. Res. Commun. 235 1997 259 263
40. H. Akamatsu, J. Komura, Y. Asada, and Y. Niwa Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation Planta Med. 57 1991 119 121
41. J.C. Fehrenbacher, M.R. Vasko, and D.B. Duarte Models of inflammation: carrageenan- or complete Freund's adjuvant-induced edema and hypersensitivity in the rat Curr. Prot. Pharmacol. 2012 1 11
42. J.R. Vane, and R.M. Botting J.R. Vane, R.M. Botting, Clinical Significance and Potential of Selective COX-2 Inhibitor 1998 William Harvey Press London
43. S.S. Agarwal Anti-inflammatory and anti-microbial activity of zuroor-e-gaozaban - a polyherbalunani formulation Hamdard Med. XLIX 2 2006 9 12